Teva - Updates, News, Events, Signals & Triggers
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Mylan sees opportunity in rival Teva's weakness - MarketWatch
Warren Buffett Stocks Fall: Teva Pharmaceutical Up 1.8%; StoneCo Off 3.7% - TheStreet
Teva Pharmaceutical Is Bottoming: Here's My Strategy - RealMoney
Why Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Is Coming Back
Teva Appoints New Chief Executive After Months of Speculation - WSJ
Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Teva and Other Opioid Defendant Stocks Jump on Strong Earnings | Barron's
Teva beats first-quarter expectations but still has the same old problems - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva stock drops 10% as generics turnaround looks uncertain - MarketWatch
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva Stock Sees Another Big Buy From Chairman Sol Barer | Barron's
Teva Stock Falls Because 2019 Will Be a 'Trough Year' | Barron's
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
TEVA | Teva Pharmaceutical Industries Ltd. ADR Stock Overview (U.S.: NYSE) | Barron's
Teva shares hit 19-year low after opioid settlement, analyst downgrades | Fierce Pharma
Drug maker Teva's U.S. unit indicted on price-fixing charges - MarketWatch
Teva Pharmaceutical Industries - Recent News & Activity
Teva Pharmaceuticals - Wikiwand
Teva Tries to Put an End to the Opioid Wars - WSJ
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva: This One Is Difficult (NYSE:TEVA) | Seeking Alpha
